In a renal environment, NLRP3-inflammasome inhibition has been related to reduced IL-1β and IL-18 levels, circulating anti-dsDNA antibodies, albuminuria, and kidney lesions, leading to a less severe LN [51,53,57]. The gene discussed is IL1B; the disease is lobular neoplasia.